These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28363474)
21. National Trends and Predictors of Organ-sparing for Invasive Penile Tumors: Expanding the Therapeutic Window. Chipollini J; Tang DH; Sharma P; Spiess PE Clin Genitourin Cancer; 2018 Apr; 16(2):e383-e389. PubMed ID: 28967504 [TBL] [Abstract][Full Text] [Related]
22. Is it possible to predict the need of inguinal lymphadenectomy in patients with squamous cell carcinoma of the penis? A clinical and a pathological study. Minardi D; Lucarini G; Simonetti O; Di Primio R; Montironi R; Muzzonigro G Arch Ital Urol Androl; 2015 Mar; 87(1):33-7. PubMed ID: 25847894 [TBL] [Abstract][Full Text] [Related]
23. Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet's node, and disease burden of inguinal lymph nodes. Zhu Y; Zhang SL; Ye DW; Yao XD; Jiang ZX; Zhou XY Onkologie; 2008 Feb; 31(1-2):37-41. PubMed ID: 18268397 [TBL] [Abstract][Full Text] [Related]
24. Cancer of the penis--a review of 50 patients. Heyns CF; van Vollenhoven P; Steenkamp JW; Allen FJ S Afr J Surg; 1997 Aug; 35(3):120-4. PubMed ID: 9429328 [TBL] [Abstract][Full Text] [Related]
25. Association between lymph node density and disease specific survival in patients with penile cancer. Svatek RS; Munsell M; Kincaid JM; Hegarty P; Slaton JW; Busby JE; Gaston KE; Spiess PE; Pagliaro LC; Tamboli P; Pettaway CA J Urol; 2009 Dec; 182(6):2721-7. PubMed ID: 19837433 [TBL] [Abstract][Full Text] [Related]
27. Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data. Ficarra V; Zattoni F; Cunico SC; Galetti TP; Luciani L; Fandella A; Guazzieri S; Maruzzi D; Sava T; Siracusano S; Pilloni S; Tasca A; Martignoni G; Gardiman M; Tardanico R; Zambolin T; Cisternino A; Artibani W; Cancer; 2005 Jun; 103(12):2507-16. PubMed ID: 15856474 [TBL] [Abstract][Full Text] [Related]
28. A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. Hegarty PK; Kayes O; Freeman A; Christopher N; Ralph DJ; Minhas S BJU Int; 2006 Sep; 98(3):526-31. PubMed ID: 16925747 [TBL] [Abstract][Full Text] [Related]
29. The role of lymphadenectomy in penile cancer. Sánchez-Ortiz RF; Pettaway CA Urol Oncol; 2004; 22(3):236-44; discussion 244-5. PubMed ID: 15271324 [TBL] [Abstract][Full Text] [Related]
30. [Treatment of the regional lymph nodes in squamous carcinoma of the penis]. Bernardo N; Scorticati C; Holst P; Soldano M; De Lasa T; Suárez P; López M; Bencardino F; Sotero Falco E; Coste Delvecchio F; Rendón F Arch Esp Urol; 1996 Oct; 49(8):813-8. PubMed ID: 9065278 [TBL] [Abstract][Full Text] [Related]
31. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases. Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153 [TBL] [Abstract][Full Text] [Related]
32. Partial penectomy for patients with squamous cell carcinoma of the penis: the Memorial Sloan-Kettering experience. Korets R; Koppie TM; Snyder ME; Russo P Ann Surg Oncol; 2007 Dec; 14(12):3614-9. PubMed ID: 17896151 [TBL] [Abstract][Full Text] [Related]
33. Extended lymphadenectomy in penile cancer. Pompeo AC Can J Urol; 2005 Feb; 12 Suppl 1():30-6; discussion 97-8. PubMed ID: 15780162 [TBL] [Abstract][Full Text] [Related]
34. Lack of P16ink4a over expression in penile squamous cell carcinoma is associated with recurrence after lymph node dissection. Tang DH; Clark PE; Giannico G; Hameed O; Chang SS; Gellert LL J Urol; 2015 Feb; 193(2):519-25. PubMed ID: 25261804 [TBL] [Abstract][Full Text] [Related]
35. Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Johnson TV; Hsiao W; Delman KA; Jani AB; Brawley OW; Master VA Cancer; 2010 Jun; 116(12):2960-6. PubMed ID: 20564401 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological Pattern of Penile Cancer in a Tertiary Care Centre in Nepal. Gupta DK; Luitel BR; Chalise PR; Subedi PP; Chapagain S; Thakur DK; Sharma UK; Gyawali PR; Shrestha GK JNMA J Nepal Med Assoc; 2015; 53(199):162-5. PubMed ID: 27549497 [TBL] [Abstract][Full Text] [Related]
38. [Five-year survival analysis in patients with penile cancer]. Montiel-Jarquín ÁJ; Contreras-Díaz AJ; Vázquez-Cruz E; Chopin-Gazga MA; Romero-Figueroa MS; Etchegaray-Morales I; Alvarado-Ortega I Rev Med Inst Mex Seguro Soc; 2017; 55 Suppl 1():S34-S43. PubMed ID: 28212473 [TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience. Pettaway CA; Pisters LL; Dinney CP; Jularbal F; Swanson DA; von Eschenbach AC; Ayala A J Urol; 1995 Dec; 154(6):1999-2003. PubMed ID: 7500444 [TBL] [Abstract][Full Text] [Related]
40. Impact of delay in inguinal lymph node dissection in patients with carcinoma of penis. Gulia AK; Mandhani A; Muruganandham K; Kapoor R; Ansari MS; Srivastava A Indian J Cancer; 2009; 46(3):214-8. PubMed ID: 19574673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]